Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

Eligibility for anti-tumour necrosis factor (TNF) therapy in most European countries is restricted to severe, active rheumatoid arthritis (RA). The DAS28 score is a marker of disease severity and incorporates one of two inflammatory markers, erythrocyte sedimentation rate (ESR) or C-reactive protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Bluett, J, Ibrahim, I, Plant, D, Hyrich, K L, Morgan, A W, Wilson, A G, Isaacs, J D, Barton, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965567/
https://www.ncbi.nlm.nih.gov/pubmed/23856853
http://dx.doi.org/10.1038/tpj.2013.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965567/
https://www.ncbi.nlm.nih.gov/pubmed/23856853
http://dx.doi.org/10.1038/tpj.2013.26

Ejemplares similares